Logo image of XPOF

XPONENTIAL FITNESS INC-A (XPOF) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:XPOF - US98422X1019 - Common Stock

5.9 USD
+0.41 (+7.47%)
Last: 11/21/2025, 8:06:25 PM
5.79 USD
-0.11 (-1.86%)
After Hours: 11/21/2025, 8:06:25 PM
Fundamental Rating

4

Taking everything into account, XPOF scores 4 out of 10 in our fundamental rating. XPOF was compared to 132 industry peers in the Hotels, Restaurants & Leisure industry. There are concerns on the financial health of XPOF while its profitability can be described as average. XPOF is valued quite cheap, while showing a decent growth score. This is a good combination!


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year XPOF was profitable.
In the past year XPOF had a positive cash flow from operations.
In the past 5 years XPOF reported 4 times negative net income.
Of the past 5 years XPOF 4 years had a positive operating cash flow.
XPOF Yearly Net Income VS EBIT VS OCF VS FCFXPOF Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

1.2 Ratios

XPOF has a Return On Assets of -15.44%. This is amonst the worse of the industry: XPOF underperforms 85.61% of its industry peers.
The Return On Invested Capital of XPOF (22.15%) is better than 93.18% of its industry peers.
The Average Return On Invested Capital over the past 3 years for XPOF is in line with the industry average of 10.41%.
The last Return On Invested Capital (22.15%) for XPOF is above the 3 year average (10.38%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -15.44%
ROE N/A
ROIC 22.15%
ROA(3y)-5.36%
ROA(5y)-7.13%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)10.38%
ROIC(5y)N/A
XPOF Yearly ROA, ROE, ROICXPOF Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

1.3 Margins

With an excellent Operating Margin value of 23.27%, XPOF belongs to the best of the industry, outperforming 87.88% of the companies in the same industry.
The Gross Margin of XPOF (78.16%) is better than 92.42% of its industry peers.
XPOF's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 23.27%
PM (TTM) N/A
GM 78.16%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.58%
GM growth 5Y3.29%
XPOF Yearly Profit, Operating, Gross MarginsXPOF Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 50 -50

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), XPOF is creating value.
The number of shares outstanding for XPOF has been increased compared to 1 year ago.
The number of shares outstanding for XPOF has been increased compared to 5 years ago.
XPOF has a worse debt/assets ratio than last year.
XPOF Yearly Shares OutstandingXPOF Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
XPOF Yearly Total Debt VS Total AssetsXPOF Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

XPOF has an Altman-Z score of -0.83. This is a bad value and indicates that XPOF is not financially healthy and even has some risk of bankruptcy.
XPOF's Altman-Z score of -0.83 is on the low side compared to the rest of the industry. XPOF is outperformed by 88.64% of its industry peers.
The Debt to FCF ratio of XPOF is 25.96, which is on the high side as it means it would take XPOF, 25.96 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of XPOF (25.96) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 25.96
Altman-Z -0.83
ROIC/WACC2.11
WACC10.52%
XPOF Yearly LT Debt VS Equity VS FCFXPOF Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

2.3 Liquidity

A Current Ratio of 1.06 indicates that XPOF should not have too much problems paying its short term obligations.
XPOF has a Current ratio of 1.06. This is comparable to the rest of the industry: XPOF outperforms 56.06% of its industry peers.
XPOF has a Quick Ratio of 1.00. This is a normal value and indicates that XPOF is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.00, XPOF perfoms like the industry average, outperforming 57.58% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.06
Quick Ratio 1
XPOF Yearly Current Assets VS Current LiabilitesXPOF Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

4

3. Growth

3.1 Past

XPOF shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 23.53%, which is quite impressive.
XPOF shows a decrease in Revenue. In the last year, the revenue decreased by -3.36%.
The Revenue has been growing by 19.93% on average over the past years. This is quite good.
EPS 1Y (TTM)23.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%950%
Revenue 1Y (TTM)-3.36%
Revenue growth 3Y27.35%
Revenue growth 5Y19.93%
Sales Q2Q%-2.07%

3.2 Future

The Earnings Per Share is expected to grow by 171.22% on average over the next years. This is a very strong growth
XPOF is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.59% yearly.
EPS Next Y516.5%
EPS Next 2Y249.83%
EPS Next 3Y171.22%
EPS Next 5YN/A
Revenue Next Year-4.01%
Revenue Next 2Y-0.83%
Revenue Next 3Y2.59%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
XPOF Yearly Revenue VS EstimatesXPOF Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
XPOF Yearly EPS VS EstimatesXPOF Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 1 -1

7

4. Valuation

4.1 Price/Earnings Ratio

XPOF is valuated quite expensively with a Price/Earnings ratio of 28.10.
The rest of the industry has a similar Price/Earnings ratio as XPOF.
The average S&P500 Price/Earnings ratio is at 25.47. XPOF is around the same levels.
The Price/Forward Earnings ratio is 5.76, which indicates a rather cheap valuation of XPOF.
Based on the Price/Forward Earnings ratio, XPOF is valued cheaper than 96.97% of the companies in the same industry.
XPOF is valuated cheaply when we compare the Price/Forward Earnings ratio to 34.42, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 28.1
Fwd PE 5.76
XPOF Price Earnings VS Forward Price EarningsXPOF Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of XPOF indicates a rather cheap valuation: XPOF is cheaper than 83.33% of the companies listed in the same industry.
XPOF's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. XPOF is cheaper than 69.70% of the companies in the same industry.
Industry RankSector Rank
P/FCF 20.84
EV/EBITDA 6.91
XPOF Per share dataXPOF EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6 -6

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as XPOF's earnings are expected to grow with 171.22% in the coming years.
PEG (NY)0.05
PEG (5Y)N/A
EPS Next 2Y249.83%
EPS Next 3Y171.22%

0

5. Dividend

5.1 Amount

XPOF does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

XPONENTIAL FITNESS INC-A

NYSE:XPOF (11/21/2025, 8:06:25 PM)

After market: 5.79 -0.11 (-1.86%)

5.9

+0.41 (+7.47%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)11-06 2025-11-06/amc
Earnings (Next)03-11 2026-03-11/amc
Inst Owners74.33%
Inst Owner Change-3.84%
Ins Owners5.11%
Ins Owner Change20.83%
Market Cap288.16M
Revenue(TTM)315.73M
Net Income(TTM)-54.86M
Analysts78.75
Price Target11.32 (91.86%)
Short Float %18%
Short Ratio7.82
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.12
Dividend Growth(5Y)N/A
DP-14.03%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)94.37%
Min EPS beat(2)16.62%
Max EPS beat(2)172.11%
EPS beat(4)2
Avg EPS beat(4)-44.73%
Min EPS beat(4)-219.74%
Max EPS beat(4)172.11%
EPS beat(8)2
Avg EPS beat(8)-60.28%
EPS beat(12)2
Avg EPS beat(12)-153.22%
EPS beat(16)2
Avg EPS beat(16)-143.54%
Revenue beat(2)1
Avg Revenue beat(2)-0.29%
Min Revenue beat(2)-3.27%
Max Revenue beat(2)2.69%
Revenue beat(4)3
Avg Revenue beat(4)0%
Min Revenue beat(4)-3.27%
Max Revenue beat(4)2.69%
Revenue beat(8)5
Avg Revenue beat(8)-0.02%
Revenue beat(12)9
Avg Revenue beat(12)1.8%
Revenue beat(16)13
Avg Revenue beat(16)4.72%
PT rev (1m)-10%
PT rev (3m)-10%
EPS NQ rev (1m)-49.11%
EPS NQ rev (3m)-60.14%
EPS NY rev (1m)0%
EPS NY rev (3m)-5.77%
Revenue NQ rev (1m)-4.45%
Revenue NQ rev (3m)-7.8%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.77%
Valuation
Industry RankSector Rank
PE 28.1
Fwd PE 5.76
P/S 0.91
P/FCF 20.84
P/OCF 15.66
P/B N/A
P/tB N/A
EV/EBITDA 6.91
EPS(TTM)0.21
EY3.56%
EPS(NY)1.02
Fwd EY17.35%
FCF(TTM)0.28
FCFY4.8%
OCF(TTM)0.38
OCFY6.39%
SpS6.46
BVpS-2.33
TBVpS-6.32
PEG (NY)0.05
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -15.44%
ROE N/A
ROCE 28.03%
ROIC 22.15%
ROICexc 26.31%
ROICexgc 227.32%
OM 23.27%
PM (TTM) N/A
GM 78.16%
FCFM 4.38%
ROA(3y)-5.36%
ROA(5y)-7.13%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)10.38%
ROIC(5y)N/A
ROICexc(3y)11.53%
ROICexc(5y)N/A
ROICexgc(3y)87.99%
ROICexgc(5y)N/A
ROCE(3y)13.14%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.58%
GM growth 5Y3.29%
F-Score5
Asset Turnover0.89
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 25.96
Debt/EBITDA 3.98
Cap/Depr 32.33%
Cap/Sales 1.45%
Interest Coverage 1.77
Cash Conversion 21%
Profit Quality N/A
Current Ratio 1.06
Quick Ratio 1
Altman-Z -0.83
F-Score5
WACC10.52%
ROIC/WACC2.11
Cap/Depr(3y)65.89%
Cap/Depr(5y)60.54%
Cap/Sales(3y)3.86%
Cap/Sales(5y)3.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)23.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%950%
EPS Next Y516.5%
EPS Next 2Y249.83%
EPS Next 3Y171.22%
EPS Next 5YN/A
Revenue 1Y (TTM)-3.36%
Revenue growth 3Y27.35%
Revenue growth 5Y19.93%
Sales Q2Q%-2.07%
Revenue Next Year-4.01%
Revenue Next 2Y-0.83%
Revenue Next 3Y2.59%
Revenue Next 5YN/A
EBIT growth 1Y3.36%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year470.54%
EBIT Next 3Y101.95%
EBIT Next 5YN/A
FCF growth 1Y-65.44%
FCF growth 3Y-17.41%
FCF growth 5YN/A
OCF growth 1Y-64.87%
OCF growth 3Y-6.86%
OCF growth 5Y49.76%

XPONENTIAL FITNESS INC-A / XPOF FAQ

Can you provide the ChartMill fundamental rating for XPONENTIAL FITNESS INC-A?

ChartMill assigns a fundamental rating of 4 / 10 to XPOF.


What is the valuation status of XPONENTIAL FITNESS INC-A (XPOF) stock?

ChartMill assigns a valuation rating of 7 / 10 to XPONENTIAL FITNESS INC-A (XPOF). This can be considered as Undervalued.


How profitable is XPONENTIAL FITNESS INC-A (XPOF) stock?

XPONENTIAL FITNESS INC-A (XPOF) has a profitability rating of 5 / 10.


Can you provide the PE and PB ratios for XPOF stock?

The Price/Earnings (PE) ratio for XPONENTIAL FITNESS INC-A (XPOF) is 28.1 and the Price/Book (PB) ratio is -2.54.


Can you provide the expected EPS growth for XPOF stock?

The Earnings per Share (EPS) of XPONENTIAL FITNESS INC-A (XPOF) is expected to grow by 516.5% in the next year.